TY - JOUR T1 - Ethnic variation in outcome of people hospitalised with Covid-19 in Wales (UK): A rapid analysis of surveillance data using Onomap, a name-based ethnicity classification tool JF - medRxiv DO - 10.1101/2020.06.22.20136036 SP - 2020.06.22.20136036 AU - Daniel Rh Thomas AU - Oghogho Orife AU - Amy Plimmer AU - Christopher Williams AU - George Karani AU - Meirion R Evans AU - Paul A Longley AU - Janusz Janiec AU - Roiyah Saltus AU - A Giri Shankar Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/26/2020.06.22.20136036.abstract N2 - There is growing evidence that ethnic minorities in Europe are disproportionately affected by Covid-19. Using a name-based ethnicity classifier, we found that hospitalised Black, Asian and minority ethnic cases were younger and more likely to be admitted to intensive care (ICU). Pakistani, Bangladeshi and White - other than British or Irish, ethnic groups were most at risk. In this study, older age and male gender, but not ethnicity, were associated with death in hospitalised patients.Competing Interest StatementPaul Longley is Director of Publicprofiler Ltd.Funding StatementNo external funding was obtained. A 12 momth licence for Onomap was purchased from Paul Longley by Public Health Wales.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This analysis was carried out as part of the ongoing response to the Covid-19 epidemic in Wales, so ethical approval was not required. Named patient data are required by Onomap to assign ethnicity. The use of named patient data in the investigation of communicable disease outbreaks and surveillance of notifiable disease is permitted under Public Health Wales Establishment Order. Data were held and processed under Public Health Wales information governance arrangements, in compliance with the Data Protection Act, Caldicott Principles and Public Health Wales guidance on the release of small numbers. No data identifying protected characteristics of an individual were released outside Public Health Wales. Permission had previously been obtained from the Confidentiality Advisory Group to process patient data on tests for viral hepatitis carried out by laboratories in Wales as part of a research study (Application title: Incidence of infectious disease in BME groups using Onomap; CAG reference: 16/CAG/0133; IRAS project ID: 210327 REC reference: 16/WS/018).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred to in the manuscript are not publicly available. ER -